On Tuesday (November 2), the U.S. Centers for Disease Control and Prevention recommended the Pfizer/BioNTech shot for broad use in that age group, four days after it was authorized by the U.S. Food and Drug Administration.
Sarah Katchur was excited to have her children vaccinated Thursday.
"And especially with being around family who's immunocompromised, I was happy to get the kids vaccinated."
Only a limited amount of the initial 15 million shots being distributed was available on Wednesday. They are expected to be more widely accessible at pediatrician's offices, children's hospitals and pharmacies next week.